GNX102

GNX102 · GlycoNex, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNX102, covering 2024-05-06 to 2024-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of GNX102 in Patients With Advanced Solid Tumors [Phase 1]